{"id":"https://openalex.org/W3096746448","doi":"https://doi.org/10.1021/acs.molpharmaceut.0c00777","title":"Synthesis and Evaluation of 68Ga- and 177Lu-Labeled ( R )- vs ( S )\u2011DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives","display_name":"Synthesis and Evaluation of 68Ga- and 177Lu-Labeled ( R )- vs ( S )\u2011DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives","publication_year":2020,"publication_date":"2020-10-27","ids":{"openalex":"https://openalex.org/W3096746448","doi":"https://doi.org/10.1021/acs.molpharmaceut.0c00777","mag":"3096746448","pmid":"https://pubmed.ncbi.nlm.nih.gov/33108189"},"language":"en","primary_location":{"id":"doi:10.1021/acs.molpharmaceut.0c00777","doi":"https://doi.org/10.1021/acs.molpharmaceut.0c00777","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.0c00777","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012856961","display_name":"Ruiyue Zhao","orcid":"https://orcid.org/0000-0001-5242-0785","observed_orcids":["https://orcid.org/0000-0001-5242-0785"]},"institutions":[{"id":"https://openalex.org/I25254941","display_name":"Beijing Normal University","ror":"https://ror.org/022k4wk35","country_code":"CN","type":"education","lineage":["https://openalex.org/I25254941"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ruiyue Zhao","raw_affiliation_strings":["Beijing Normal University , , ,","College of Chemistry, Beijing Normal University, Beijing 100875, PR China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beijing Normal University , , ,","institution_ids":["https://openalex.org/I25254941"]},{"raw_affiliation_string":"College of Chemistry, Beijing Normal University, Beijing 100875, PR China","institution_ids":["https://openalex.org/I25254941"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027454270","display_name":"Karl Pl\u00f6essl","orcid":"https://orcid.org/0000-0001-7896-5900","observed_orcids":["https://orcid.org/0000-0001-7896-5900"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karl Ploessl","raw_affiliation_strings":["Five Eleven Pharma Inc. , , ,","Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States"],"raw_orcid":"https://orcid.org/0000-0001-7896-5900","affiliations":[{"raw_affiliation_string":"Five Eleven Pharma Inc. , , ,","institution_ids":[]},{"raw_affiliation_string":"Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087004464","display_name":"Zhihao Zha","orcid":"https://orcid.org/0009-0000-5360-3962","observed_orcids":["https://orcid.org/0009-0000-5360-3962"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhihao Zha","raw_affiliation_strings":["Five Eleven Pharma Inc. , , ,","Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Five Eleven Pharma Inc. , , ,","institution_ids":[]},{"raw_affiliation_string":"Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004522320","display_name":"Seok-Rye Choi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seokrye Choi","raw_affiliation_strings":["Five Eleven Pharma Inc. , , ,","Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Five Eleven Pharma Inc. , , ,","institution_ids":[]},{"raw_affiliation_string":"Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025961784","display_name":"David Alexoff","orcid":"https://orcid.org/0000-0002-0612-1239","observed_orcids":["https://orcid.org/0000-0002-0612-1239"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Alexoff","raw_affiliation_strings":["Five Eleven Pharma Inc. , , ,","Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Five Eleven Pharma Inc. , , ,","institution_ids":[]},{"raw_affiliation_string":"Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100664607","display_name":"Lin Zhu","orcid":"https://orcid.org/0000-0001-9530-8531","observed_orcids":["https://orcid.org/0000-0001-9530-8531"]},"institutions":[{"id":"https://openalex.org/I25254941","display_name":"Beijing Normal University","ror":"https://ror.org/022k4wk35","country_code":"CN","type":"education","lineage":["https://openalex.org/I25254941"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lin Zhu","raw_affiliation_strings":["Beijing Normal University , , ,","College of Chemistry, Beijing Normal University, Beijing 100875, PR China"],"raw_orcid":"https://orcid.org/0000-0001-9530-8531","affiliations":[{"raw_affiliation_string":"Beijing Normal University , , ,","institution_ids":["https://openalex.org/I25254941"]},{"raw_affiliation_string":"College of Chemistry, Beijing Normal University, Beijing 100875, PR China","institution_ids":["https://openalex.org/I25254941"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055131918","display_name":"Hank F. Kung","orcid":"https://orcid.org/0000-0003-3254-8049","observed_orcids":["https://orcid.org/0000-0003-3254-8049"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hank F. Kung","raw_affiliation_strings":["Five Eleven Pharma Inc. , , ,","University of Pennsylvania , , , ,","Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States","Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Five Eleven Pharma Inc. , , ,","institution_ids":[]},{"raw_affiliation_string":"University of Pennsylvania , , , ,","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5055131918"],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":1.2163,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.80366762,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"17","issue":"12","first_page":"4589","last_page":"4602"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dotaga","display_name":"DOTAGA","score":0.722000002861023},{"id":"https://openalex.org/keywords/68ga-radiolabeling","display_name":"68Ga radiolabeling","score":0.7490000128746033},{"id":"https://openalex.org/keywords/radionuclide-therapy","display_name":"radionuclide therapy","score":0.753000020980835},{"id":"https://openalex.org/keywords/prostate-cancer-imaging","display_name":"prostate cancer imaging","score":0.7559999823570251},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.5189999938011169},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.8230000138282776},{"id":"https://openalex.org/keywords/radiopharmaceutical-synthesis","display_name":"radiopharmaceutical synthesis","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.8562904000282288},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7330238819122314},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.6792019605636597},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6617145538330078},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.6467524170875549},{"id":"https://openalex.org/C20417620","wikidata":"https://www.wikidata.org/wiki/Q4140229","display_name":"Glutamate carboxypeptidase II","level":4,"score":0.625312089920044},{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.5066131353378296},{"id":"https://openalex.org/C177322064","wikidata":"https://www.wikidata.org/wiki/Q750955","display_name":"Radiochemistry","level":1,"score":0.4867556095123291},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.47446590662002563},{"id":"https://openalex.org/C2984398910","wikidata":"https://www.wikidata.org/wiki/Q849737","display_name":"Spect imaging","level":2,"score":0.45294731855392456},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.4227115213871002},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3827766478061676},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.37399551272392273},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2831069827079773},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.2594159245491028},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.175613135099411},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1208389401435852},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08804765343666077},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000954","descriptor_name":"Antigens, Surface","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002614","descriptor_name":"Chelating Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002614","descriptor_name":"Chelating Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D002614","descriptor_name":"Chelating Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005710","descriptor_name":"Gallium Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008187","descriptor_name":"Lutetium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D011868","descriptor_name":"Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015335","descriptor_name":"Molecular Probes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015335","descriptor_name":"Molecular Probes","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D015335","descriptor_name":"Molecular Probes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043425","descriptor_name":"Glutamate Carboxypeptidase II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057054","descriptor_name":"Molecular Imaging","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.molpharmaceut.0c00777","doi":"https://doi.org/10.1021/acs.molpharmaceut.0c00777","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.0c00777","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:33108189","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33108189","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W1610851198","https://openalex.org/W1942708746","https://openalex.org/W1966335626","https://openalex.org/W1969458610","https://openalex.org/W1981509653","https://openalex.org/W1989226016","https://openalex.org/W1997403945","https://openalex.org/W2002972210","https://openalex.org/W2023230827","https://openalex.org/W2035619243","https://openalex.org/W2042925728","https://openalex.org/W2057327251","https://openalex.org/W2069824662","https://openalex.org/W2078968671","https://openalex.org/W2119643174","https://openalex.org/W2151649292","https://openalex.org/W2155847415","https://openalex.org/W2170794639","https://openalex.org/W2175765437","https://openalex.org/W2287576637","https://openalex.org/W2603534867","https://openalex.org/W2781324280","https://openalex.org/W2787120891","https://openalex.org/W2799825908","https://openalex.org/W2800232471","https://openalex.org/W2894392370","https://openalex.org/W2898883116","https://openalex.org/W2911188335","https://openalex.org/W2911522675","https://openalex.org/W2913023403","https://openalex.org/W2923457014","https://openalex.org/W2945560655","https://openalex.org/W2965362447","https://openalex.org/W2968136389","https://openalex.org/W2971958940","https://openalex.org/W2995068778","https://openalex.org/W2996012248","https://openalex.org/W2996117498","https://openalex.org/W2996649940","https://openalex.org/W2999417355","https://openalex.org/W2999653667","https://openalex.org/W3008190193","https://openalex.org/W3009386304","https://openalex.org/W3014199979","https://openalex.org/W3026921270","https://openalex.org/W3027729807","https://openalex.org/W3082635082","https://openalex.org/W3087151197"],"related_works":["https://openalex.org/W4295788270","https://openalex.org/W4399490365","https://openalex.org/W2155847415","https://openalex.org/W4224771907","https://openalex.org/W2795846502","https://openalex.org/W2151048211","https://openalex.org/W4416978220","https://openalex.org/W7167584152","https://openalex.org/W2239135329","https://openalex.org/W2781324280"],"abstract_inverted_index":{"Abstract":[0],"Prostate-specific":[1],"membrane":[2],"antigen":[3],"(PSMA)":[4],"is":[5,13,77,206],"overexpressed":[6],"in":[7,58,189,247,256],"prostate":[8,18,49],"cancer":[9,19],"cells":[10],"and":[11,21,93,97,109,120,133,158,186,203,215],"therefore":[12],"an":[14],"attractive":[15],"target":[16],"for":[17,45,73,80,85,146],"diagnosis":[20,47],"radionuclide":[22,86,253],"therapy.":[23,87],"Recently,":[24],"published":[25],"results":[26],"from":[27],"clinical":[28],"studies":[29,188,226],"using":[30],"a":[31,211],"new":[32,251],"PSMA-targeting":[33],"PET":[34],"imaging":[35],"agent,":[36,176],"[68Ga]\u00adGa-PSMA-093":[37],"([68Ga]\u00adGa-HBED-CC-O-carboxymethyl-Tyr-CO-NH-Glu),":[38],"support":[39],"the":[40,46,54,112,134,147,174,200,207,228,235,238,248,257],"development":[41,249],"of":[42,48,103,118,128,136,143,173,183,213,218,224,240,250],"this":[43,52],"agent":[44],"cancer.":[50],"In":[51],"study,":[53],"HBED-CC":[55],"chelating":[56,68,74],"group":[57,69],"PSMA-093":[59],"was":[60,115,138],"replaced":[61],"by":[62],"stereoselective":[63],"(R)-":[64,92,202],"or":[65],"(S)-DOTAGA.":[66],"This":[67,205],"serves":[70],"not":[71],"only":[72],"68Ga":[75,149],"but":[76],"also":[78],"amendable":[79],"complexing":[81],"other":[82],"radioactive":[83],"metals":[84],"The":[88,141,156],"corresponding":[89,148],"optically":[90],"pure":[91],"(S)-[68Ga/177Lu]-DOTAGA":[94],"derivatives,":[95],"(R)-[68Ga/177Lu]-13":[96],"(S)-[68Ga/177Lu]-13,":[98],"were":[99,131,151,221],"successfully":[100],"prepared.":[101],"Comparison":[102],"radiolabeling,":[104],"binding":[105,163],"affinity,":[106],"cell":[107,184],"uptake,":[108],"biodistribution":[110,187],"between":[111,153,199,227],"two":[113],"isomers":[114,217,229],"performed.":[116],"Radiolabeling":[117],"(R)-[177Lu]\u00adLu-13":[119],"(S)-[177Lu]\u00adLu-13":[121,137],"at":[122],"50":[123],"\u00b0C":[124],"suggested":[125],"that":[126,172,210],"rates":[127,142],"complex":[129,144,242],"formation":[130,135,145,243],"time-dependent":[132],"distinctly":[139],"faster.":[140],"agents":[150,220,255],"comparable":[152,170],"structural":[154],"isomers.":[155],"natGa":[157],"natLu":[159],"equivalents":[160],"showed":[161,230],"high":[162],"PSMA":[164,219],"affinity":[165],"(IC50":[166,178],"=":[167,179],"24\u2013111":[168],"nM),":[169],"to":[171,195],"parent":[175],"[natGa]\u00adGa-PSMA-093":[177],"34.0":[180],"nM).":[181],"Results":[182,223],"uptake":[185],"PSMA-expressing":[190],"PC3-PIP":[191],"tumor-bearing":[192],"mice":[193],"appeared":[194],"show":[196],"no":[197,231],"difference":[198],"labeled":[201],"(S)-isomers.":[204],"first":[208],"time":[209],"pair":[212],"[68Ga/177Lu]-(R)-":[214],"(S)-DOTAGA":[216],"evaluated.":[222],"biological":[225],"noticeable":[232],"difference;":[233],"however,":[234],"distinctions":[236],"on":[237],"rate":[239],"Lu":[241],"should":[244],"be":[245],"considered":[246],"177Lu-DOTAGA-based":[252],"therapy":[254],"future.":[258]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-11-09T00:00:00"}